WallStreetZenWallStreetZen

NASDAQ: ATHE
Alterity Therapeutics Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ATHE stock forecasts and price targets.

Forecast return on equity

Is ATHE forecast to generate an efficient return?

Company
0%
Industry
285.59%
Market
231.17%
ATHE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ATHE forecast to generate an efficient return on assets?

Company
0%
Industry
96.56%
ATHE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ATHE earnings per share forecast

What is ATHE's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$0.00
Avg 2 year Forecast
$0.00
Avg 3 year Forecast
$0.00

ATHE revenue forecast

What is ATHE's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$4.1M-18.54%
Avg 2 year Forecast
$3.8M-23.58%
Avg 3 year Forecast
$39.1M+676.96%
ATHE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ATHE revenue growth forecast

How is ATHE forecast to perform vs Biotechnology companies and vs the US market?

Company
87.93%
Industry
109.05%
Market
25.77%
ATHE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ATHE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ATHE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ATHE$3.46N/AN/A
TCRX$1.09$6.00+450.46%Buy
EQ$1.10N/AN/A
COEP$13.71N/AN/A
CRVO$6.92$22.80+229.48%Strong Buy
View Top Biotech Stocks

Alterity Therapeutics Stock Forecast FAQ

What is ATHE's earnings growth forecast for 2026-2028?

(NASDAQ: ATHE) Alterity Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 47.92%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.93%.

Alterity Therapeutics's earnings in 2025 is -$7,939,756.On average, 2 Wall Street analysts forecast ATHE's earnings for 2026 to be $0, with the lowest ATHE earnings forecast at $0, and the highest ATHE earnings forecast at $0. On average, 2 Wall Street analysts forecast ATHE's earnings for 2027 to be $0, with the lowest ATHE earnings forecast at $0, and the highest ATHE earnings forecast at $0.

In 2028, ATHE is forecast to generate $0 in earnings, with the lowest earnings forecast at $0 and the highest earnings forecast at $0.

If you're new to stock investing, here's how to buy Alterity Therapeutics stock.

What is ATHE's revenue growth forecast for 2026-2028?

(NASDAQ: ATHE) Alterity Therapeutics's forecast annual revenue growth rate of 87.93% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 109.05%, and while it is forecast to beat the US market's average forecast revenue growth rate of 25.77%.

Alterity Therapeutics's revenue in 2025 is $4,994,454.On average, 3 Wall Street analysts forecast ATHE's revenue for 2026 to be $37,376,582,959, with the lowest ATHE revenue forecast at $0, and the highest ATHE revenue forecast at $77,710,434,021. On average, 3 Wall Street analysts forecast ATHE's revenue for 2027 to be $35,067,358,176, with the lowest ATHE revenue forecast at $0, and the highest ATHE revenue forecast at $72,918,564,410.

In 2028, ATHE is forecast to generate $356,515,098,995 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $741,261,155,522.

What is ATHE's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: ATHE) forecast ROA is 0%, which is lower than the forecast US Biotechnology industry average of 96.56%.

What is ATHE's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ATHE) Alterity Therapeutics's current Earnings Per Share (EPS) is -$0.75. On average, analysts forecast that ATHE's EPS will be $0.00 for 2026, with the lowest EPS forecast at $0.00, and the highest EPS forecast at $0.00. On average, analysts forecast that ATHE's EPS will be $0.00 for 2027, with the lowest EPS forecast at $0.00, and the highest EPS forecast at $0.00. In 2028, ATHE's EPS is forecast to hit $0.00 (min: $0.00, max: $0.00).

What is ATHE's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: ATHE) forecast ROE is 0%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.